Colgate-Palmolive is a global leader in toothpaste and manual toothbrushes that is now repositioning itself around premium, science-led innovation and omni-channel demand generation through its 2030 strategy, and the question for the next twelve months is whether the company can convert the 41.3% global toothpaste market share, the 32.7% global manual toothbrush market share, the 4.9% net sales growth, the 2.4% organic sales growth, the 61.5% gross margin, the 8% Base Business EPS growth, and the 15% advertising increase into the kind of premium-innovation-driven growth the company has been telegraphing. The Q2 2026 print was the cleanest test of that thesis, and the cleanest signal is that CEO Noel Wallace said "our growth momentum continued in the second quarter, as we delivered strong broad-based top- and bottom-line results, despite a difficult operating environment. Net sales and organic sales grew in three of four categories and in four of five divisions with worldwide organic volume growth improving sequentially for the third consecutive quarter." The strategic tension is the -5% GAAP EPS decline against the +8% Base Business EPS growth, and the forward question is whether the private label pet food exit can clear the way for the 2030 strategy to deliver the mid-single-digit Base Business EPS growth the company has been telegraphing.
The 41.3% global toothpaste market share and the 32.7% global manual toothbrush market share are the cleanest read on the competitive moat, and the 2030 strategy is the proof. The Q2 2026 net sales of $5.361 billion grew 4.9% year over year, the Q2 2026 organic sales grew 2.4% including a 0.4% negative impact from lower private label pet food sales, the Q2 2026 GAAP gross profit margin expanded 140 basis points to 61.5%, the Q2 2026 GAAP EPS decreased 5% to $0.86, and the Q2 2026 Base Business EPS increased 8% to $0.99.
The Q2 2026 net cash provided by operations was $1.742 billion for the first six months of 2026. The Q2 2026 worldwide organic volume growth improved sequentially for the third consecutive quarter. The Q2 2026 advertising increased 15%. The forward question is whether the private label pet food exit can clear the way for the 2030 strategy to deliver the mid-single-digit Base Business EPS growth.